Best HealthTech Companies in Oxford, United Kingdom
The 76 best HealthTech companies in Oxford, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Exscientia.
Our analysis of 80 HealthTech companies
$5.5b in tracked funding; 96% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in Oxford
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Exscientia Developer of artificial intelligence software for identifying potential drug candidates | $429M | 30 mo ago | — | Chris Gibson Co-Founder & CEO | — | 81 patents Patents concentrated in chemistry & materials | — |
| 2 | OXSIGHT Developer of AI-enabled vision loss devices for visually impaired individuals | $275M | 97 mo ago | 8 | Christopher Kennard Co-Founder | — | 15 patents Assistive visual augmentation via head‑mounted displays and image‑enhancement for low‑vision users | — |
| 3 | Genomics Provider of a platform for the analysis of genomic sequence data 67Patents top 20%Moat top 21%Innovation top 24%Funding top 30% All 13 signals ▾Patentstop 20% Moattop 21% Innovationtop 24% Fundingtop 30% Partnerstop 32% Producttop 35% Talenttop 35% Markettop 41% Growthtop 49% Fin. healthbottom 46% Globalbottom 45% Techbottom 33% Newsbottom 21% Patents: 48 patents matched (strict assignee match) · 33 filings since 2022 vs 13 in 2017-21 Moat: Editorial + unicorn rating 8/10 · IP moat: 48 patents rank vs industry peers · Fliar Intelligence Index 67/100 | $146M | 29 mo ago | 76 76 → 184 (+142%) | Peter Donnelly Co-Founder & CEO | — | 48 patents Software tools for computational analysis of genomic sequence data | 2 awards |
| 4 | Perspectum Developer of medical imaging software for analyzing chronic liver diseases 84AI top 15%Patents top 19%Innovation top 28%Funding top 28% All 11 signals ▾AItop 15% Patentstop 19% Innovationtop 28% Fundingtop 28% Moattop 28% Growthtop 34% Techtop 34% Fin. healthtop 35% Markettop 38% Talenttop 38% Globalbottom 47% AI: Holds AI/ML patents (G06N-family CPC) Patents: 65 patents matched (strict assignee match) · 53 filings since 2022 vs 12 in 2017-21 rank vs industry peers · Fliar Intelligence Index 84/100 | $121M | 39 mo ago | 196 196 → 273 (+39%) | Michael Brady Co-Founder | WordPressMySQLPHP+31 | 65 patents Quantitative medical imaging analysis and MRI temperature correction for diagnostic radiology | — |
| 5 | Osler Diagnostics Developer of portable diagnostic instruments for rapid point of care | $85M | 43 mo ago | 76 | Paulo Bueno Co-Founder | Apple iCloud MailMicrosoft 365Vimeo+8 | 95 patents Automated liquid handling and sample preparation for clinical diagnostic analysis | — |
| 6 | Ultromics Developer of artificial intelligence software for analyzing cardiac ultrasound images 67Funding top 27%News top 28%AI top 30%Moat top 31% All 12 signals ▾Fundingtop 27% Newstop 28% AItop 30% Moattop 31% Growthtop 33% Talenttop 38% Innovationtop 39% Patentstop 40% Techtop 50% Marketbottom 49% Fin. healthbottom 46% Globalbottom 42% Funding: Raised $60.6M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) News: 4 BI events in 12 mo (of 7 tracked, 2 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 67/100 | $61M | 6 mo ago | 49 49 → 85 (+73%) | Ross Upton Co-Founder & CEO | HubSpot CMS HubApple iCloud MailMicrosoft 365+22 | 9 patents AI-driven analysis of cardiac imaging for heart function assessment | 1 launch |
| 7 | Brainomix Developer of automated medical imaging software for stroke and lung 64AI top 18%Funding top 28%Patents top 31%Fin. health top 35% All 13 signals ▾AItop 18% Fundingtop 28% Patentstop 31% Fin. healthtop 35% Producttop 40% Innovationtop 42% Growthtop 46% Moattop 46% Techtop 47% Talentbottom 49% Marketbottom 45% Globalbottom 45% Newsbottom 37% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $34.8M across 8 rounds · 8 rounds over 12 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $35M | 8 mo ago | 29 | Michalis Papadakis Co-Founder & CEO | Apple iCloud MailMicrosoft 365Salesforce+27 | 19 patents Patents concentrated in computing, sensing & instrumentation | — |
| 8 | Optellum Provider of AI-based cancer diagnostics platform | $21M | 44 mo ago | 28 28 → 52 (+86%) | Timor Kadir Co-Founder & CTO | WordPressMySQLPHP+29 | 60 patents AI-powered medical imaging analysis and predictive analytics for oncology outcomes | 2 partnerships |
| 9 | Caristo Diagnostics Developer of technology for cardiac disease risk assessment and analysis | $19M | 38 mo ago | 20 | Stefan Neubauer Co-Founder | WordPressMySQLPHP+27 | 4 patents Radiomic analysis of medical imaging for vascular disease detection and risk assessment | 2 awards |
| 10 | Orbit Discovery Developer of a drug discovery platforms by peptide display engine | $16M | 48 mo ago | 26 26 → 32 (+23%) | Neil Butt CEO | WebflowYouTubeUmami+13 | — | — |
| 11 | Oxford Drug Design Provider of computer-aided design of antibiotics for MDR infections 32Talent top 28%Funding top 30%Moat top 32%Patents top 38% All 9 signals ▾Talenttop 28% Fundingtop 30% Moattop 32% Patentstop 38% Innovationtop 40% Producttop 41% Globalbottom 40% Marketbottom 26% Techbottom 23% Talent: Analyst team rating 4/5 · 3 named leaders on record Funding: Raised $12.4M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $12M | 4 mo ago | 9 | Graham Richards Founder & Chairman | — | 46 patents Antibacterial aminoacyl‑tRNA synthetase inhibitors based on sulfonamide/aryl acetamide scaffolds. | — |
| 12 | Akrivia Health Provider of an AI-based clinical research database and management software for researches | $12M | 60 mo ago | 20 | David Newton Co-Founder | WordPress Block EditorElementorWordPress+32 | — | — |
| 13 | Scripta Therapeutics Developer of therapeutics modulating transcription factor activity for disease treatment 27Funding top 36%Talent top 38%Tech bottom 49%Global bottom 45% All 5 signals ▾Fundingtop 36% Talenttop 38% Techbottom 49% Globalbottom 45% Marketbottom 25% Funding: Raised $11.9M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 27/100 | $12M | 7 mo ago | — | Jerry Huang Co-Founder & VP Machine Learning | Framer SitesApple iCloud MailReact+13 | — | — |
| 14 | Mirada Medical Software products that use medical images to diagnose and treat cancer | $8M | 86 mo ago | 81 81 → 42 (-48%) | Hugh Bettesworth Founder & Director | — | 99 patents AI-driven medical imaging analysis, uncertainty quantification, and radiotherapy planning tools. | 2 job openings |
| 15 | Ufonia Provider of post operative assessment and monitoring services for hospitals | $4M | 45 mo ago | 11 | Nick Pennington Founder & CEO | WordPressApple iCloud MailGoogle Workspace+17 | — | 2 job openings |
| 16 | Ground Truth Labs Provider of a digital pathology annotation tool for researchers and clinicians | $4M | 35 mo ago | 1 | Jens Rittscher Co-Founder & CSO | — | 3 patents Automated generation of data visualizations and visual analytics interfaces. | — |
| 17 | Caeruleus Genomics A computational biotech company focused on functional cell profiling and target discovery | $4M | 18 mo ago | — | Adam Cribbs Co-Founder & CTO | — | — | — |
| 18 | PicturaBio Provider of digital imaging platform for the detection of pathogens | $4M | 36 mo ago | 5 | Alex Batchelor Co-Founder & CEO | — | — | 1 job opening |
| 19 | Coding Bio AI-assisted platform for cell therapy development 19AI top 45%Talent top 45%Funding top 49%Global bottom 36% All 5 signals ▾AItop 45% Talenttop 45% Fundingtop 49% Globalbottom 36% Marketbottom 19% AI: Product described with: machine learning Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 19/100 | $3M | 5 mo ago | 5 | Yulia Lampi Co-Founder | — | — | — |
| 20 | Neurolytic Healthcare Developer of smart medical devices to improve the treatment of neurological disorders | $3M | 46 mo ago | 5 | Roman Rothaermel Co-Founder & CEO | — | — | — |
| 21 | Kudos Provider of research communication and showcase services. | $3M | 71 mo ago | 12 | Melinda Kenneway Co-Founder & CEO | — | — | — |
| 22 | Nye Provider of an online doctor consultation platform | $2M | 61 mo ago | 12 | Alexander Finlayson CEO | — | — | — |
| 23 | colwiz Reference management platform for researchers | $2M | 168 mo ago | 4 | — | — | — | — |
| 24 | Cognitant Cloud-based telehealth solution for healthcare providers | $2M | 32 mo ago | 19 | Juhi Saltzstein Co-Founder | — | — | — |
| 25 | Informatics Matters Digital cheminformatics research management tool for drug discovery | $881K | 113 mo ago | 3 | Tim Dudgeon Owner | — | — | — |
| 26 | GaitQ Developer of a device to prevent gait freeze for Parkinsons patients | $858K | 62 mo ago | 5 | James Cantley Co-Founder | — | — | — |
| 27 | Physiomics Provider of virtual tumour technology based solutions for pre-clinical and clinical development | $705K | 97 mo ago | 7 | Jim Millen CEO | WordPressMySQLPHP+31 | — | — |
| 28 | Stayf Workforce health and safety platform for businesses | $704K | 26 mo ago | — | Kirill P Co-Founder & COO | WebflowSegmentMicrosoft Advertising+27 | — | — |
| 29 | Jack Fertility Provider of at home sperm testing kits | $668K | 8 mo ago | 5 | Lily Elsner Co-Founder & CEO | — | — | — |
| 30 | Evolvere BioSciences Developer of next generation antibiotics using artificial intelligence models to outpace bacterial resistance | $500K | 24 mo ago | — | Weronika Ślesak Co-Founder | — | — | — |
| 31 | Yoxly Online platform offering at-home sexually transmitted infection testing kits | $467K | 27 mo ago | 8 | Danae Maragouthakis Co-founder | Cart FunctionalityShopifyBuilder.io+36 | — | — |
| 32 | Sentimoto Smartwatch for monitoring elderly care and management | $254K | 106 mo ago | 3 | — | — | 2 patents Voice activity detection algorithms for speech/audio signal processing | — |
| 33 | Precisionlife Developer of AI-driven precision medicine for complex and chronic diseases | $217K | 52 mo ago | 30 30 → 33 (+10%) | Rowan Gardner Co-Founder & Chief Business and Investment Officer | HubSpot CMS HubVimeoEnvoy+15 | — | — |
| 34 | Adelie Health Provider of device and app for managing insulin dosage | $107K | 88 mo ago | 1 | Liam Morrow Founder | — | — | — |
Top 12 HealthTech companies in Oxford
#1
Series C · Oxford, England · founded 2017 · 49 employees$60.6Mraised▾
Developer of artificial intelligence software for analyzing cardiac ultrasound images. This technology processes echocardiogram video clips to identify patterns associated with specific heart conditions. The software integrates with existing medical imaging systems to provide automated reports for clinical review. These tools assist in the detection of heart failure and other cardiovascular abnormalities by identifying findings within routine diagnostic scans. The system functions through cloud-based infrastructure to deliver results directly into clinical workflows.
- Dec 2025Series C—
- Jul 2025Series C$55M
- Aug 2021Series B$33M
- Sep 2020Series A$272K
#2
Series A · Oxford, England · founded 2001 · 9 employees$12.4Mraised▾
Oxford Drug Design is a spinoff from the laboratory of Dr. Graham Richards at the University of Oxford and is focusing on developing novel antibiotics for multi-drug resistance bacterial infections. The company has developed a fast virtual screening and ligand analog searching platform to speed up the drug discovery process. Called 3D ElectroShape technology, the approach involves the use of their proprietary compound databases (containing over 23 million unique molecules), and a combination of structure- and ligand-based virtual screening to find ligands for target proteins.
- Feb 2026Series A$981.8K
- May 2022Series A$2.7M
- Nov 2019Series A$2.8M
- Nov 2019Grant (prize money)—
#3
Series C · Oxford, England · founded 2010 · 29 employees$34.8Mraised▾
Developer of automated medical imaging software for stroke and lung. This technology processes medical scans to identify biomarkers and assist in clinical assessment. The software provides automated analysis for stroke detection and lung disease evaluation. These tools support diagnostic workflows by generating insights from imaging data to assist in treatment decisions.
- Oct 2025Series C$6.5M
- Jan 2025Series C$18M
- May 2023Series B—
- Dec 2021Series B$21.7M
#4
Seed · Oxford, England · founded 2025$11.9Mraised▾
Developer of therapeutics modulating transcription factor activity for disease treatment. It focuses on identifying and manipulating master controllers of biology. The company utilizes AI/ML models to reveal novel therapeutics. It validates results in patient-derived models, initially targeting neurodegenerative diseases.
- Nov 2025Seed$11.9M
#5
Seed · Oxford, England · founded 2021 · 5 employees$3.4Mraised▾
AI-assisted platform for cell therapy development. The platform utilizes machine learning technology to screen and identify lead candidates (Chimeric Antigen Receptors) for cell therapy. It uses automation & computation technology for the identification of Chimeric Antigen Receptor (CRAs) for therapeutics.
- Jan 2026Seed—
- Nov 2022Seed$475.7K
- Nov 2022Seed$3M
#6
Acquired · Oxford, England · founded 2012$428.6Mraised▾
Developer of artificial intelligence software for identifying potential drug candidates. This technology utilizes biological and chemical datasets to analyze cellular images and identify disease targets. The platform facilitates the design of molecules for therapeutic applications in oncology and rare diseases. Automated laboratory systems capture experimental data to refine machine learning models used in the drug discovery process. These computational tools assist in the identification of treatments for conditions with unmet medical needs.
- Dec 2023Grant (prize money)$2.3M
- Oct 2021Post IPO$160M
- Jul 2021Grant (prize money)$1.5M
- Apr 2021Series D$225M
#7
Seed · Oxford, England · founded 2022 · 5 employees$667.6Kraised▾
Provider of at-home sperm testing kits. It offers a from-home, mail in sperm test kit that provide personalised insights for improving sperm health for seeking specialist help. It allows users to collect a sperm sample at home, then send it by mail to laboratory. It also enables users to receive comprehensive, lab-grade semen analysis results digitally, including sperm motility, morphology, count, concentration, and volume.
- Oct 2025Seed$667.6K
- Aug 2023Seed—
#8
Series C · Oxford, England · founded 2014 · 76 employees$145.5Mraised▾
Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. The company uses an analytical platform for genomic sequence data investigation and consultancy which maximizes the impact of DNA sequencing and helps to identify individuals at risk of particular diseases, enabling pharmaceutical businesses to avail a genomic engine that de-risks the drug development process and provides improved healthcare.
#9
Seed · Oxford, England · founded 2023$4Mraised▾
A computational biotech company focused on functional cell profiling and target discovery. It specializes in human-centric discovery using a proprietary single-cell long-read sequencing platform to profile human tissues functionally, uncover RNA targets, and develop effective therapies.
- Dec 2024Seed$2.8M
- Jan 2023Seed$1.2M
#10
Series C · Oxford, England · founded 2012 · 196 employees$121.2Mraised▾
Developer of medical imaging software for analyzing chronic liver diseases. This technology extracts biomarkers from magnetic resonance imaging scans to assist in the assessment of metabolic and gastrointestinal conditions. The software processes complex imaging data to provide quantitative insights for clinical diagnosis and monitoring. These tools support research efforts and clinical decision-making processes regarding patient health management.
- Mar 2023Series C$19M
- Jan 2023Series C$35.9M
- Apr 2020Series B$36M
- Oct 2017Grant (prize money)$366.1K
#11
Series C · Oxford, England · founded 2017 · 76 employees$85Mraised▾
Developer of portable diagnostic instruments for rapid point of care. These systems utilize microfluidic sample preparation and electrochemical biosensing to perform quantitative analysis. The technology enables the consolidation of multiple testing procedures onto a single instrument for use in various clinical settings.
- Nov 2022Series C$85M
#12
Series A · Oxford, England · founded 2016 · 8 employees$275Mraised▾
Developer of AI-enabled vision loss devices for visually impaired individuals. The company has developed a smart glass that can be used for visual loss for assistance. The glasses assist with central and peripheral vision loss problems
- May 2018Series A$271M
- Nov 2017Seed$2M
- Jun 2016Seed$2.1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
How research on Digital Health in Oxford is moving
A read on the academic research around Digital Health in Oxford — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 248 papers.
- University of Oxford193
- Mahidol Oxford Tropical Medicine Research Unit15
- Oxford University Hospitals NHS Trust12
- Oxford Health NHS Foundation Trust12
- Science Oxford10
- Wearable computer1→5
- Health care2→15
- Public health2→7
- Intervention (counseling)1→6
- Health informatics8→11
- MEDLINE1→4
- Health care2→55
- Psychological intervention1→20
- Public health7→20
- Health informatics10→20
- Nursing research2→11
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.